Founded by physician-scientists more than 30 years ago, our science-driven approach has resulted in seven FDA-approved medicines and numerous product candidates in a range of diseases, including cancer, asthma, pain and infectious diseases.
In addition to our medicines, our innovations include the VelociSuite® technologies, world-class manufacturing operations, one of the largest human sequencing efforts in the world and rapid response technologies being used for global good.
2020 Annual Meeting of Shareholders
10:30 AM EDT Jun 12, 2020 | 10:30 AM EDT
Regeneron Oncology Investor Event, ASCO 2020
4:30 PM EDT Jun 1, 2020 | 4:30 PM EDT
Bernstein's 36th Annual Strategic Decisions Conference
10:00 AM EDT May 27, 2020 | 10:00 AM EDT